As of 2026-05-22, the Relative Valuation of Santen Pharmaceutical Co Ltd (4536.T) is 1,359.64 JPY. This relative valuation is based on P/E multiples. With the latest stock price at 1,902.50 JPY, the upside of Santen Pharmaceutical Co Ltd based on Relative Valuation is -28.5%.
The range of the Relative Valuation is 972.53 - 2,083.20 JPY.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 15.6x | 11.6x |
| Forward P/E multiples | 11.4x - 18.9x | 14.8x |
| Fair Price | 972.53 - 2,083.20 | 1,359.64 |
| Upside | -48.9% - 9.5% | -28.5% |
| Date | P/E |
| 2026-05-20 | 20.03 |
| 2026-05-19 | 19.94 |
| 2026-05-18 | 19.42 |
| 2026-05-15 | 19.60 |
| 2026-05-14 | 19.82 |
| 2026-05-13 | 19.11 |
| 2026-05-12 | 16.44 |
| 2026-05-11 | 17.08 |
| 2026-05-08 | 17.03 |
| 2026-05-07 | 17.15 |
| 2026-05-01 | 17.30 |
| 2026-04-30 | 17.02 |
| 2026-04-28 | 17.38 |
| 2026-04-27 | 17.35 |
| 2026-04-24 | 17.63 |
| 2026-04-23 | 17.51 |
| 2026-04-22 | 17.72 |
| 2026-04-21 | 18.08 |
| 2026-04-20 | 18.45 |
| 2026-04-17 | 18.66 |
| 2026-04-16 | 18.76 |
| 2026-04-15 | 18.96 |
| 2026-04-14 | 18.95 |
| 2026-04-13 | 19.02 |
| 2026-04-10 | 19.23 |
| 2026-04-09 | 19.97 |
| 2026-04-08 | 20.33 |
| 2026-04-07 | 19.91 |
| 2026-04-06 | 19.75 |
| 2026-04-03 | 19.22 |
| 2026-04-02 | 19.16 |
| 2026-04-01 | 19.47 |
| 2026-03-31 | 18.80 |
| 2026-03-30 | 18.59 |
| 2026-03-27 | 18.82 |
| 2026-03-26 | 18.51 |
| 2026-03-25 | 18.23 |
| 2026-03-24 | 18.07 |
| 2026-03-23 | 17.37 |
| 2026-03-19 | 17.76 |
| 2026-03-18 | 17.79 |
| 2026-03-17 | 17.76 |
| 2026-03-16 | 17.43 |
| 2026-03-13 | 17.28 |
| 2026-03-12 | 17.19 |
| 2026-03-11 | 17.62 |
| 2026-03-10 | 17.44 |
| 2026-03-09 | 17.04 |
| 2026-03-06 | 17.05 |
| 2026-03-05 | 17.07 |